arrow
C

Clemens Aigner

University Duisburg-Essen
H指数:43
被引数:6,324

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of Homing Receptors and Activation-Linked Surface Antigens on Human Mast Cells and Basophils

鉴定人肥大细胞和嗜碱性粒细胞上的归巢受体及活化相关表面抗原

2026-10-130
OAAI
Transcriptional landscape of pulmonary artery endothelium reveals subpopulation- and disease-specific remodeling signatures

肺动脉内皮细胞转录组景观揭示了亚群特异性和疾病特异性的重塑特征

2026-05-110
OAAI
A single-cell atlas revealing cellular heterogeneity across healthy and diseased human thymus

单细胞图谱揭示健康与疾病状态下人胸腺的细胞异质性

2026-05-060
OAAI
Investigation of sterile hydrogels as topical vehicles for APOSECTM, a stressed peripheral blood mononuclear cell secretome for the treatment of poorly healing wounds

研究无菌水凝胶作为APOSECTM(一种应激外周血单核细胞分泌组)治疗难愈合伤口的局部载体

2026-04-300
PRE
Immune-related markers define clinically relevant prognostic subgroups in thymic epithelial tumors

免疫相关标记物定义胸腺上皮肿瘤的临床相关预后亚组

2026-04-300
OAAI
FILONEX – A Prospective, Randomized Controlled Pilot Safety Study Evaluating the Addition of Hemodiafiltration to EVLP in Marginal Donor Lungs

FILONEX——一项前瞻性、随机对照的初步安全性研究,评估在边缘供体肺中向体外膜肺氧合(EVLP)添加血液透析滤过(Hemodiafiltration)的可行性

2026-04-220
OAAI
Long-term outcomes of preoperative nivolumab with or without relatlimab in patients with resectable non-small-cell lung cancer (NEOpredict-Lung)

可切除非小细胞肺癌患者术前纳武利尤单抗联合或不联合雷迪利单抗的长期结局(NEOpredict-Lung)

2025-12-050
PREAI
Refining Risk Stratification and Surveillance Strategies in Pleuropulmonary Solitary Fibrous Tumors—An International, Retrospective, Multicenter Analysis

优化胸膜肺孤立性纤维瘤的风险分层和监测策略——一项国际、回顾性、多中心分析

2025-12-050
OAAI
Outcome of patients with curative-intent treatment for primary pulmonary sarcoma: Results from an international multicenter retrospective study

原发性肺肉瘤根治性治疗患者的结局:一项国际多中心回顾性研究的结果

2025-12-011
OAAI
Pathologic Complete Response Predicts Long-Term Survival Following Neoadjuvant Induction Chemotherapy and Chemo-Radiotherapy in Stage-III Non-Small Cell Lung Cancer

病理完全缓解预测III期非小细胞肺癌新辅助诱导化疗及放化疗后的长期生存率

2025-11-190
OAAI
Surgical Results after Neoadjuvant Nivolumab and Platinum-based Chemotherapy for Resectable Lung Cancer. A Multicentre European Real Clinical Practice Analysis

新辅助纳武利尤单抗联合铂类化疗治疗可切除肺癌的手术结果。一项多中心欧洲真实临床实践分析

2025-10-010
PRE
The Contingency of Reported sST2 Serum Concentrations with a Protein Detection System (ELISA) from the Same Manufacturer (R&D Biotechne, 2002–2025): An Explanatory Effort by Applied Medical Researchers

使用同一制造商(R&D Biotechne,2002–2025)的蛋白质检测系统(ELISA)检测报告的sST2血清浓度的偶然性:医学应用研究人员的解释性努力

2025-09-300
OAAI
254: Going All In - Using Dual ECMO Circuits To Stabilize Rapidly Progressing Interstitial Lung Disease Lung Transplant Candidates: An International Case Series

254: 全力以赴——使用双ECMO回路稳定快速进展的间质性肺病患者,以使其成为肺移植候选人:一项国际病例系列研究

2025-09-260
PRE